臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"hsu c"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 461-485 of 881 (36 Page(s) Totally)
<< < 14 15 16 17 18 19 20 21 22 23 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2020-09-29T06:53:04Z	Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer	Kuo S.-H.; Cheng A.-L.; Tien Y.-W.; Yeh K.-H.; Hsu C.-H.; Hsu C.; Wu H.; Guo J.-C.; TING-CHUN KUO; Yang S.-H.
臺大學術典藏	2020-09-29T01:47:44Z	Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers	Yeh K.-H.; Cheng A.-L.; Yang J.C.-H.; Kao H.-F.; Chen I.-C.; Hsu C.; Chang S.-Y.; Chien S.-F.; YEE-CHUN CHEN; Hu F.-C.
臺大學術典藏	2020-09-23T07:36:15Z	Diagnostic value of 18F-FDG-PET/CT in indeterminate infiltrative hepatic lesions in an endemic area of viral hepatitis	Mei-Fang Cheng;Wu Y.-W.;Liu K.-L.;Yen R.-F.;Wu Y.-M.;Hsu C.;Chang Y.-T.;Tzen K.-Y.;Wang H.-P.; MEI-FANG CHENG; Wu Y.-W.; Liu K.-L.; Yen R.-F.; Wu Y.-M.; Hsu C.; Chang Y.-T.; Tzen K.-Y.; Wang H.-P.
臺大學術典藏	2020-09-23T06:22:40Z	Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate	Hsu C.; Hong R.-L.; Tzen C.-Y.; Jeng Y.-M.; RUOH-FANG YEN; Lin C.-H.; Lin C.-H.;Ruoh-Fang Yen;Jeng Y.-M.;Tzen C.-Y.;Hsu C.;Hong R.-L.
臺大學術典藏	2020-09-23T06:22:31Z	Diagnostic value of 18F-FDG-PET/CT in indeterminate infiltrative hepatic lesions in an endemic area of viral hepatitis	Cheng M.-F.; Wu Y.-W.; Liu K.-L.; RUOH-FANG YEN; Wu Y.-M.; Hsu C.; Chang Y.-T.; Tzen K.-Y.; Wang H.-P.
臺大學術典藏	2020-09-22T07:39:54Z	Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil	Chao-Yu Hsu ;Shen Y.-C. ;Yu C.-W. ;Hsu C. ;Hu F.-C. ;Hsu C.-H. ;Chen B.-B. ;Wei S.-Y. ;Cheng A.-L. ;Shih T.T.-F.; CHAO-YU HSU; Shen Y.-C.; Yu C.-W.; Hsu C.; Hu F.-C.; Hsu C.-H.; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.
臺大學術典藏	2020-09-22T07:39:51Z	Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy	Shih T.T.-F.; Cheng A.-L.; Hsu C.-H.; Hsu C.; Liang P.-C.; Chen B.-B.; CHAO-YU HSU; Yu C.-W.
臺大學術典藏	2020-09-22T07:39:50Z	Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma	Chen B.-B.;Chao-Yu Hsu;Yu C.-W.;Liang P.-C.;Hsu C.;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; Chen B.-B.; CHAO-YU HSU; Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F.
臺大學術典藏	2020-08-14T03:15:33Z	Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies	Chen B.-B.; I-LUN SHIH; Wu C.-H.; Hsu C.; Chen C.-H.; Shih T.T.-F.; Liu K.-L.; Liang P.-C.
臺大學術典藏	2020-08-14T03:15:30Z	Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; I-LUN SHIH; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2020-08-13T06:34:06Z	Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status	Su W.-P.; Yang C.-H.; Yu C.-J.; JIN-YUAN SHIH; Hsu C.; Yang P.-C.; Su W.-P.;Yang C.-H.;Yu C.-J.;Jin-Yuan Shih;Hsu C.;Yang P.-C.
臺大學術典藏	2020-08-13T06:34:05Z	Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer	Lin C.-P.; Su W.-P.; Gow C.-H.; Hsu C.; Chang G.-C.; Yang P.-C.; Yu C.-J.; Yang T.-Y.; Yang C.-H.; JIN-YUAN SHIH; Chen K.-C.
臺大學術典藏	2020-08-13T06:33:59Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	Yang C.-H.; Yang P.-C.; Huang T.-C.; Lin C.-C.; Yu C.-J.; Hsu C.; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; JIN-YUAN SHIH
臺大學術典藏	2020-08-12T06:35:54Z	Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials	CHONG-JEN YU; Hsu C.; Cheng A.-L.; Yang P.-C.; Kuo S.-H.; Yang C.-H.; Kuo S.-H.;Yang C.-H.;Chong-Jen Yu;Hsu C.;Cheng A.-L.;Yang P.-C.
臺大學術典藏	2020-08-12T06:35:50Z	Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status	Su W.-P.;Yang C.-H.;Chong-Jen Yu;Shih J.-Y.;Hsu C.;Yang P.-C.; Su W.-P.; Yang C.-H.; CHONG-JEN YU; Shih J.-Y.; Hsu C.; Yang P.-C.
臺大學術典藏	2020-08-12T06:35:41Z	Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers	Chen J.-P.;Lo Y.;Chong-Jen Yu;Hsu C.;Shih J.-Y.;Yang C.-H.; Chen J.-P.; Lo Y.; CHONG-JEN YU; Hsu C.; Shih J.-Y.; Yang C.-H.
臺大學術典藏	2020-08-12T06:35:40Z	Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment	Lin Z.-Z.;Hsu C.;Chang Y.-C.;Chong-Jen Yu;Hsu C.-H.;Lin C.-C.;Cheng A.-L.;Yang P.-C.;Yang C.-H.; Lin Z.-Z.; Hsu C.; Chang Y.-C.; CHONG-JEN YU; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H.
臺大學術典藏	2020-08-12T02:42:39Z	Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma	Bang-Bin Chen;Hsu C.-Y.;Yu C.-W.;Liang P.-C.;Hsu C.;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; BANG-BIN CHEN; Hsu C.-Y.; Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F.
臺大學術典藏	2020-08-12T02:42:37Z	A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy	Chao Y.; Hsu C.; Lee R.-C.; Lin Z.-Z.; BANG-BIN CHEN; Hung Y.-P.; Huang P.-H.; Shen Y.-C.; Shao Y.-Y.; Hsu C.-H.; Cheng A.-L.; Lin Z.-Z.;Bang-Bin Chen;Hung Y.-P.;Huang P.-H.;Shen Y.-C.;Shao Y.-Y.;Hsu C.-H.;Cheng A.-L.;Lee R.-C.;Chao Y.;Hsu C.
臺大學術典藏	2020-08-11T08:36:58Z	Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: A preliminary result	PO-CHIN LIANG; Ch'ang H.-J.; Hsu C.; Tseng S.S.; Shih T.T.F.; Wu Liu T.
臺大學術典藏	2020-08-11T08:36:56Z	Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer	Chang Y.-T.; Chang M.-C.; Wei S.-C.; Tien Y.-W.; Hsu C.; PO-CHIN LIANG; Tsao P.-N.; Jan I.-S.; Wong J.-M.
臺大學術典藏	2020-08-11T08:36:51Z	A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy	Shao Y.-Y.; PO-CHIN LIANG; Wu Y.-M.; Huang C.-C.; Huang K.-W.; Cheng J.C.; Hsu C.-H.; Hsu C.; Cheng A.-L.; Lin Z.-Z.
臺大學術典藏	2020-08-11T08:36:48Z	Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies	Chen B.-B.; Shih I.-L.; Wu C.-H.; Hsu C.; Chen C.-H.; Shih T.T.-F.; PO-CHIN LIANG; Liu K.-L.
臺大學術典藏	2020-08-11T08:36:46Z	Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide	PO-CHIN LIANG; Ch’ang H.-J.; Hsu C.; Chen L.-T.; Shih T.T.F.; Liu T.W.
臺大學術典藏	2020-08-11T08:36:45Z	Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy	Chen B.-B.; Hsu C.-Y.; Yu C.-W.; PO-CHIN LIANG; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F.

Showing items 461-485 of 881 (36 Page(s) Totally)
<< < 14 15 16 17 18 19 20 21 22 23 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 0
	???header.visitor??? : 52807027 ???header.onlineuser??? : 568 ???header.sponsordeclaration???